Biotech Stocks: Geron rallies on FDA move; Merck slides (at MarketWatch)
July 30, 2010
Geron Corp. shares rallied early Friday on news that the U.S. Food and Drug Administration is allowing the company to proceed with the world s first clinical study to test an embryonic-stem-cell therapy on humans.
Klik hier voor het volledige verhaal
Annoncer:
Andre Nyheder
- UPDATE – HudBay operating results rise; NYSE listing planned (at Reuters)
- [$$] Old Favorites Day (at TheStreet.com)
- China passeert Japan als tweede economie ter wereld
- GM investeert 500 miljoen dollar in Mexico
- Zuid-Europa: hete soep
- Crush of mud finally plugs BP’s well in the Gulf
Kommentarer
